These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 18342639)

  • 1. Metals in Alzheimer's and Parkinson's diseases.
    Barnham KJ; Bush AI
    Curr Opin Chem Biol; 2008 Apr; 12(2):222-8. PubMed ID: 18342639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The transition metals copper and iron in neurodegenerative diseases.
    Rivera-Mancía S; Pérez-Neri I; Ríos C; Tristán-López L; Rivera-Espinosa L; Montes S
    Chem Biol Interact; 2010 Jul; 186(2):184-99. PubMed ID: 20399203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological inorganic and bioinorganic chemistry of neurodegeneration based on prion and Alzheimer diseases.
    Brown DR; Kozlowski H
    Dalton Trans; 2004 Jul; (13):1907-17. PubMed ID: 15252577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Misframed proteins and neurodegeneration: a novel view on Alzheimer's and Parkinson's diseases.
    Dennissen FJ; Kholod N; Steinbusch HW; Van Leeuwen FW
    Neurodegener Dis; 2010; 7(1-3):76-9. PubMed ID: 20173331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Copper homeostasis and neurodegenerative disorders (Alzheimer's, prion, and Parkinson's diseases and amyotrophic lateral sclerosis).
    Gaggelli E; Kozlowski H; Valensin D; Valensin G
    Chem Rev; 2006 Jun; 106(6):1995-2044. PubMed ID: 16771441
    [No Abstract]   [Full Text] [Related]  

  • 6. Biological metals and Alzheimer's disease: implications for therapeutics and diagnostics.
    Duce JA; Bush AI
    Prog Neurobiol; 2010 Sep; 92(1):1-18. PubMed ID: 20444428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The modulation of metal bio-availability as a therapeutic strategy for the treatment of Alzheimer's disease.
    Crouch PJ; White AR; Bush AI
    FEBS J; 2007 Aug; 274(15):3775-83. PubMed ID: 17617225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain proteins that mind metals: a neurodegenerative perspective.
    Brown DR
    Dalton Trans; 2009 Jun; (21):4069-76. PubMed ID: 19452053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metal dyshomeostasis and oxidative stress in Alzheimer's disease.
    Greenough MA; Camakaris J; Bush AI
    Neurochem Int; 2013 Apr; 62(5):540-55. PubMed ID: 22982299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Copper and Alzheimer's disease.
    Donnelly PS; Xiao Z; Wedd AG
    Curr Opin Chem Biol; 2007 Apr; 11(2):128-33. PubMed ID: 17300982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel D-penicillamine carrying nanoparticles for metal chelation therapy in Alzheimer's and other CNS diseases.
    Cui Z; Lockman PR; Atwood CS; Hsu CH; Gupte A; Allen DD; Mumper RJ
    Eur J Pharm Biopharm; 2005 Feb; 59(2):263-72. PubMed ID: 15661498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug development based on the metals hypothesis of Alzheimer's disease.
    Bush AI
    J Alzheimers Dis; 2008 Oct; 15(2):223-40. PubMed ID: 18953111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of metals in neurodegenerative diseases.
    Sayre LM; Perry G; Atwood CS; Smith MA
    Cell Mol Biol (Noisy-le-grand); 2000 Jun; 46(4):731-41. PubMed ID: 10875436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The metal theory of Alzheimer's disease.
    Bush AI
    J Alzheimers Dis; 2013; 33 Suppl 1():S277-81. PubMed ID: 22635102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aluminum exposure through the diet: metal levels in AbetaPP transgenic mice, a model for Alzheimer's disease.
    Gómez M; Esparza JL; Cabré M; García T; Domingo JL
    Toxicology; 2008 Jul; 249(2-3):214-9. PubMed ID: 18571827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excitotoxicity and new antiglutamatergic strategies in Parkinson's disease and Alzheimer's disease.
    Koutsilieri E; Riederer P
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S329-31. PubMed ID: 18267259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutics for Alzheimer's disease based on the metal hypothesis.
    Bush AI; Tanzi RE
    Neurotherapeutics; 2008 Jul; 5(3):421-32. PubMed ID: 18625454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological metals and metal-targeting compounds in major neurodegenerative diseases.
    Barnham KJ; Bush AI
    Chem Soc Rev; 2014 Oct; 43(19):6727-49. PubMed ID: 25099276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alteration of peripheral markers of copper homeostasis in Alzheimer's disease patients: implications in aetiology and therapy.
    Rossi L; Squitti R; Calabrese L; Rotilio G; Rossini PM
    J Nutr Health Aging; 2007; 11(5):408-17. PubMed ID: 17657362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metal homeostasis in Alzheimer's disease.
    White AR; Barnham KJ; Bush AI
    Expert Rev Neurother; 2006 May; 6(5):711-22. PubMed ID: 16734519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.